Kimberly-Clark, Starbucks Push Deal Boom Toward $4 Trillion

Dealmakers inked mergers and acquisitions worth more than $80 billion on Monday as they hurtle toward their second best year on record.

Leading the latest haul is Kimberly-Clark Corp., which has agreed to buy struggling Tylenol maker Kenvue Inc. for roughly $40 billion. Kimberly-Clark said the tie-up would allow it to overtake Unilever Plc and become the second-biggest seller of health and wellness products after Procter & Gamble Co. Also in the consumer sector, Starbucks Corp. is selling a majority stake in its China business to private equity firm Boyu Capital at a $4 billion enterprise value.